BD to offer a drug delivery system with a safety guard that automatically locks into place
BD (Becton, Dickinson and Company), a global medical technology company, has agreed to buy Safety Syringes, a privately held California-based company that specialises in the development of anti-needlestick devices for prefilled syringes.
The acquisition, which is subject to the satisfaction of customary closing conditions, including regulatory approvals, is expected to close by the end of BD's fiscal year 2012.
Financial terms were not disclosed.
William Kozy, BD’s executive vice president, said: ‘This pending acquisition is well aligned to BD’s strategy of applying technology and clinical knowledge to make healthcare more effective, efficient and safe. Developments for parenteral drug delivery systems continue to be a part of BD's long-term strategy.
Safety Syringe’s UltraSafe passive products are specifically designed for prefillable syringes. They provide a drug delivery system with a safety guard that passively (automatically) locks into place, delivering easy-to-use injury protection and safety.
‘We believe BD’s prefillable syringe expertise, combined with Safety Syringes' product portfolio and device development expertise, will enable new and innovative safety technology development to prepare the next generation of safety-engineered prefillable syringes,’ said Claude Dartiguelongue, president, BD Medical – Pharmaceutical Systems.